Cardiac Implantable Electronic Device Therapy for Bradyarrhythmias and Tachyarrhythmias

Pacemakers originally were developed for patients with profound bradycardia and complete heart block who, without them, usually suffered from syncope, heart failure and an early demise. Since that time, devices have evolved to include pacing and shock therapies for the management of tachyarrhythmias...

Full description

Saved in:
Bibliographic Details
Published in:Heart, lung & circulation lung & circulation, 2012-06, Vol.21 (6), p.328-337
Main Authors: Corcoran, Susan J., FRACP, Davis, Lloyd M., PhD
Format: Article
Language:English
Subjects:
Arrhythmia
Bradycardia - therapy
Cardiovascular
Defibrillators, Implantable
Heart Block - therapy
Humans
Implantable cardioverter defibrillator
Pacemaker, Artificial
Pacemakers
Quality of Life
Tachycardia - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pacemakers originally were developed for patients with profound bradycardia and complete heart block who, without them, usually suffered from syncope, heart failure and an early demise. Since that time, devices have evolved to include pacing and shock therapies for the management of tachyarrhythmias and heart failure with the aim of improving quality, and if possible, length of life. Whether to insert a device depends on a balance between the potential benefits of device therapy and its risks, which are not inconsiderable. We discuss current agreed indications for pacemakers and implantable defibrillators and some current controversies surrounding their use.
ISSN:1443-9506
1444-2892
DOI:10.1016/j.hlc.2012.03.009